Xenia Kobeleva

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

Henk-Jan Westeneng, Thomas P. A. Debray, Anne E Visser et al. · The Lancet Neurology · 2018 · 492 citations · Full text

Prognostic Assessment, Neurodegenerative Diseases, Personalised Prediction Model +12

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Frank Jessen, Steffen Wolfsgruber, Luca Kleineindam et al. · Alzheimer s & Dementia · 2022 · 98 citations · Full text

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst et al. · The Lancet Neurology · 2018 · 78 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Medicine +5

Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients

Luis R. Peraza, Ruth Cromarty, Xenia Kobeleva et al. · Scientific Reports · 2018 · 67 citations · Full text